Definitive Healthcare reports financial results for second quarter fiscal year 2022
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended June 30, 2022.
Definitive Healthcare to present at the Canaccord Genuity 42nd Annual Growth Conference
Definitive Healthcare (Nasdaq: DH) will present at the Canaccord Genuity 42nd Annual Conference on August 10, 2022.
Definitive Healthcare wins three Stevie® American Business Awards® for customer service
Definitive Healthcare was named a winner of three Stevie® Awards in the 20th Annual American Business Awards®.
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards.
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
Definitive Healthcare announced the general availability of Passport Express, the newest product in the Passport Analytics Suite.
Definitive Healthcare announces timing of its second quarter 2022 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) announced that its second quarter ended June 30, 2022 financial results will be released on Thursday, August 4…
Definitive Healthcare launches Monocl ExpertInsight 2.0 and ExpertGO mobile app
Definitive Healthcare announces the availability of Monocl ExpertInsight 2.0 and a new mobile app ExpertGO
Definitive Healthcare to present at the Stifel 2022 Cross Sector Insight Conference
Definitive Healthcare’s Chief Executive Officer, its Chief Financial Officer, and its President, will present at the Stifel 2022 Cross Sector Insight…
Definitive Healthcare launches certification program and announces Apex Award winners at Definitive LIVE!
Definitive Healthcare (Nasdaq: DH) launches customer certification and announces winners of the Apex Award.